Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

XVIIIth International Symposium on Atherosclerosis

Toronto, Canada 9-12 June 2018

ISA 2018 report: PCSK9 much yet to learn

ISA 2018 report: PCSK9 much yet to learn

PCSK9: Mechanistic insights can offer new therapeutic approaches With the completion of the second of the cardiovascular outcomes studies with the PCSK9 monoclonal antibodies, the PCSK9 story could be thought to be done and dusted. However, as highlighted by Dr Nabil Seidah, Director, Laboratory of…

read more »
ISA 2018 report: ODYSSEY Outcomes analysis shows that lipoprotein(a) is a marker of cardiovascular risk

ISA 2018 report: ODYSSEY Outcomes analysis shows that lipoprotein(a) is a marker of cardiovascular risk

ISA 2018 provided more news from the ODYSSEY Outcomes study. According to an analysis presented by Dr Vera Bittner (University of Alabama at Birmingham, USA), baseline lipoprotein(a) was an independent predictor of major adverse cardiovascular events (MACE) in patients with a recent acute coronary syndrome…

read more »